ArticleBMC psychiatry2024

Management of obesity with semaglutide or metformin in patients with antipsychotic-induced weight gain (MOSA): a non-randomised open-label pilot study.

Bea Campforts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.